Allan Steven Jacobson is a corporate insider at PTC THERAPEUTICS, INC. (PTCT). Jacobson has reported 3 insider filings with the SEC since 2025. The most recent filing was in November 2025.
Every role Allan Steven Jacobson has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
PTC THERAPEUTICS, INC. (PTCT)3 filingsUpdated Aug 31, 2026
Allan Steven Jacobson files SEC Form 4 reports at PTC THERAPEUTICS, INC. (PTCT). 3 SEC Form 4 filings on record, most recently on 26 November 2025. Most recent open-market trade: sold $60K of PTCT on 26 November 2025. Lifetime open-market sales: $3.00M.
Every recent SEC Form 4 transaction Allan Steven Jacobson has reported, most recent first.
InsiderAlpha's records for Allan Steven Jacobson go back to 2025: 3 primary Form 4 filings, an average of 1.5 per year. 21 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Insiders who reported open-market trades in the last 12 months at the companies Allan Steven Jacobson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Allan Steven Jacobson is a corporate insider of PTC THERAPEUTICS, INC. (PTCT). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
The most recent primary Form 4 on record is dated 26 November 2025, one of 3 filings going back to 2025.
Recorded transactions: 0 open-market purchases and 12 open-market sales ($3.00M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial